Clinical Trials Browser

Phase 3 × NIH × Vorinostat × Clear all

NCT01802333 2018-12-19

Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia

Phase 3 Completed

754 enrolled 20 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute